Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guide...
Gespeichert in:
Veröffentlicht in: | PloS one 2021-11, Vol.16 (11), p.e0260320-e0260320 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0260320 |
---|---|
container_issue | 11 |
container_start_page | e0260320 |
container_title | PloS one |
container_volume | 16 |
creator | Eskridge, Wayne Vierling, John M Gosbee, Wayne Wan, Gabriella A Hyunh, May-Linh Chang, Henry E |
description | The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guidelines do not recommend the routine screening of nonalcoholic fatty liver disease (NAFLD) for asymptomatic populations, so providers are not encouraged to actively seek disease, even in high-risk patients. This study sought to determine whether a self-selecting cohort of asymptomatic individuals would have scores based on vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) significantly correlated to risk factors to suggest that routine screening for high-risk patients should be recommended. The study recruited 1,070 self-selected participants in Houston and Galveston County, Texas, 940 of which were included in final analysis. A pre-screening survey was used to determine eligibility. VCTE-based scores analyzed steatosis and fibrosis levels. Fifty-seven percent of the study population demonstrated steatosis without fibrosis, suggesting NAFLD, while 16% demonstrated both steatosis and fibrosis, suggesting NASH. Statistically significant risk factors included factors related to metabolic syndrome, race, and age, while statistically significant protective factors included consumption of certain foods and exercise. The findings of this study suggest that high-risk individuals should be screened for NAFLD even in the absence of symptoms and that community-based screenings are an effective tool, particularly in the absence of proactive guidelines for providers. |
doi_str_mv | 10.1371/journal.pone.0260320 |
format | Article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2604821983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6db50ebd9eee47edb077a78a6d7f5ec2</doaj_id><sourcerecordid>2604821983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-d7ff915613bbea639f30394a049d8786a0da3322777deecc72ced6a0005ef00b3</originalsourceid><addsrcrecordid>eNptks9uEzEQxlcIREvhDRBY4pIcUrzrjb3bA1JVWlqpgkMLV2vWnk0cHHuxvZXyljwSTptWbcXJ1vg33_zxVxTvS3pYMlF-XvkxOLCHg3d4SCtOWUVfFPtly6oZryh7-ei-V7yJcUXpnDWcvy72WN3Uopzz_eLvlQqIzrgF6X0go9MGFs5H1MR5NwOr_NJbo0gPKW2INTcYiDYRISKZfD8-u_w6JeCe0zEhJL_EAZJJJm7Jq_PpETkmgx9Gm6MZ72BbJpj4O6urlMtDjBjjGl0iY9z2dGO6cAsT5V0K3tqckQK4aLYQWojJLwIMyw2Z_Dq5Pp2-LV71YCO-250Hxc-z0-uT89nlj28XJ8eXMzWveJpp0fdt3kDJug6Bs7ZnlLU10LrVjWg4UA2MVZUQQiMqJSqFOkfzDrGntGMHxcc73cH6KHefEWX-h7qpyrZhmbi4I7SHlRyCWUPYSA9G3gZ8WEgIySiLkutuTrHTLSLWAnVHhQDRAM9tzlFVWevLrtrYrVGrPHwA-0T06YszS7nwN7LhrOTZGwfFZCcQ_J8RY5JrExVaCw79eNv3vKq44CKjn56h_5-uvqNU8DEG7B-aKancGvQ-S24NKncGzWkfHg_ykHTvSPYP38jpdw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604821983</pqid></control><display><type>article</type><title>Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Eskridge, Wayne ; Vierling, John M ; Gosbee, Wayne ; Wan, Gabriella A ; Hyunh, May-Linh ; Chang, Henry E</creator><contributor>Tokuhara, Daisuke</contributor><creatorcontrib>Eskridge, Wayne ; Vierling, John M ; Gosbee, Wayne ; Wan, Gabriella A ; Hyunh, May-Linh ; Chang, Henry E ; Tokuhara, Daisuke</creatorcontrib><description>The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guidelines do not recommend the routine screening of nonalcoholic fatty liver disease (NAFLD) for asymptomatic populations, so providers are not encouraged to actively seek disease, even in high-risk patients. This study sought to determine whether a self-selecting cohort of asymptomatic individuals would have scores based on vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) significantly correlated to risk factors to suggest that routine screening for high-risk patients should be recommended. The study recruited 1,070 self-selected participants in Houston and Galveston County, Texas, 940 of which were included in final analysis. A pre-screening survey was used to determine eligibility. VCTE-based scores analyzed steatosis and fibrosis levels. Fifty-seven percent of the study population demonstrated steatosis without fibrosis, suggesting NAFLD, while 16% demonstrated both steatosis and fibrosis, suggesting NASH. Statistically significant risk factors included factors related to metabolic syndrome, race, and age, while statistically significant protective factors included consumption of certain foods and exercise. The findings of this study suggest that high-risk individuals should be screened for NAFLD even in the absence of symptoms and that community-based screenings are an effective tool, particularly in the absence of proactive guidelines for providers.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0260320</identifier><identifier>PMID: 34847156</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alcohol ; Asymptomatic ; Attenuation ; Biology and Life Sciences ; Biopsy ; Comorbidity ; Diabetes ; Elasticity Imaging Techniques ; Fatty liver ; Female ; Fibrosis ; Food consumption ; Guidelines ; Health risks ; Humans ; Hypertension ; Lifestyles ; Liver ; Liver diseases ; Male ; Medicine and Health Sciences ; Metabolic disorders ; Metabolic syndrome ; Middle Aged ; Non-alcoholic Fatty Liver Disease - diagnostic imaging ; Patients ; Population ; Population studies ; Risk analysis ; Risk Factors ; Risk groups ; Signs and symptoms ; Statistical analysis ; Steatosis ; Transplants & implants ; Ultrasonic imaging ; Vibration ; Weight control</subject><ispartof>PloS one, 2021-11, Vol.16 (11), p.e0260320-e0260320</ispartof><rights>2021 Eskridge et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Eskridge et al 2021 Eskridge et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-d7ff915613bbea639f30394a049d8786a0da3322777deecc72ced6a0005ef00b3</citedby><cites>FETCH-LOGICAL-c526t-d7ff915613bbea639f30394a049d8786a0da3322777deecc72ced6a0005ef00b3</cites><orcidid>0000-0002-9717-5194 ; 0000-0001-5547-6020</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631660/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631660/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34847156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Tokuhara, Daisuke</contributor><creatorcontrib>Eskridge, Wayne</creatorcontrib><creatorcontrib>Vierling, John M</creatorcontrib><creatorcontrib>Gosbee, Wayne</creatorcontrib><creatorcontrib>Wan, Gabriella A</creatorcontrib><creatorcontrib>Hyunh, May-Linh</creatorcontrib><creatorcontrib>Chang, Henry E</creatorcontrib><title>Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guidelines do not recommend the routine screening of nonalcoholic fatty liver disease (NAFLD) for asymptomatic populations, so providers are not encouraged to actively seek disease, even in high-risk patients. This study sought to determine whether a self-selecting cohort of asymptomatic individuals would have scores based on vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) significantly correlated to risk factors to suggest that routine screening for high-risk patients should be recommended. The study recruited 1,070 self-selected participants in Houston and Galveston County, Texas, 940 of which were included in final analysis. A pre-screening survey was used to determine eligibility. VCTE-based scores analyzed steatosis and fibrosis levels. Fifty-seven percent of the study population demonstrated steatosis without fibrosis, suggesting NAFLD, while 16% demonstrated both steatosis and fibrosis, suggesting NASH. Statistically significant risk factors included factors related to metabolic syndrome, race, and age, while statistically significant protective factors included consumption of certain foods and exercise. The findings of this study suggest that high-risk individuals should be screened for NAFLD even in the absence of symptoms and that community-based screenings are an effective tool, particularly in the absence of proactive guidelines for providers.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alcohol</subject><subject>Asymptomatic</subject><subject>Attenuation</subject><subject>Biology and Life Sciences</subject><subject>Biopsy</subject><subject>Comorbidity</subject><subject>Diabetes</subject><subject>Elasticity Imaging Techniques</subject><subject>Fatty liver</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Food consumption</subject><subject>Guidelines</subject><subject>Health risks</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Lifestyles</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Male</subject><subject>Medicine and Health Sciences</subject><subject>Metabolic disorders</subject><subject>Metabolic syndrome</subject><subject>Middle Aged</subject><subject>Non-alcoholic Fatty Liver Disease - diagnostic imaging</subject><subject>Patients</subject><subject>Population</subject><subject>Population studies</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Risk groups</subject><subject>Signs and symptoms</subject><subject>Statistical analysis</subject><subject>Steatosis</subject><subject>Transplants & implants</subject><subject>Ultrasonic imaging</subject><subject>Vibration</subject><subject>Weight control</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNptks9uEzEQxlcIREvhDRBY4pIcUrzrjb3bA1JVWlqpgkMLV2vWnk0cHHuxvZXyljwSTptWbcXJ1vg33_zxVxTvS3pYMlF-XvkxOLCHg3d4SCtOWUVfFPtly6oZryh7-ei-V7yJcUXpnDWcvy72WN3Uopzz_eLvlQqIzrgF6X0go9MGFs5H1MR5NwOr_NJbo0gPKW2INTcYiDYRISKZfD8-u_w6JeCe0zEhJL_EAZJJJm7Jq_PpETkmgx9Gm6MZ72BbJpj4O6urlMtDjBjjGl0iY9z2dGO6cAsT5V0K3tqckQK4aLYQWojJLwIMyw2Z_Dq5Pp2-LV71YCO-250Hxc-z0-uT89nlj28XJ8eXMzWveJpp0fdt3kDJug6Bs7ZnlLU10LrVjWg4UA2MVZUQQiMqJSqFOkfzDrGntGMHxcc73cH6KHefEWX-h7qpyrZhmbi4I7SHlRyCWUPYSA9G3gZ8WEgIySiLkutuTrHTLSLWAnVHhQDRAM9tzlFVWevLrtrYrVGrPHwA-0T06YszS7nwN7LhrOTZGwfFZCcQ_J8RY5JrExVaCw79eNv3vKq44CKjn56h_5-uvqNU8DEG7B-aKancGvQ-S24NKncGzWkfHg_ykHTvSPYP38jpdw</recordid><startdate>20211130</startdate><enddate>20211130</enddate><creator>Eskridge, Wayne</creator><creator>Vierling, John M</creator><creator>Gosbee, Wayne</creator><creator>Wan, Gabriella A</creator><creator>Hyunh, May-Linh</creator><creator>Chang, Henry E</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9717-5194</orcidid><orcidid>https://orcid.org/0000-0001-5547-6020</orcidid></search><sort><creationdate>20211130</creationdate><title>Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)</title><author>Eskridge, Wayne ; Vierling, John M ; Gosbee, Wayne ; Wan, Gabriella A ; Hyunh, May-Linh ; Chang, Henry E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-d7ff915613bbea639f30394a049d8786a0da3322777deecc72ced6a0005ef00b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alcohol</topic><topic>Asymptomatic</topic><topic>Attenuation</topic><topic>Biology and Life Sciences</topic><topic>Biopsy</topic><topic>Comorbidity</topic><topic>Diabetes</topic><topic>Elasticity Imaging Techniques</topic><topic>Fatty liver</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Food consumption</topic><topic>Guidelines</topic><topic>Health risks</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Lifestyles</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Male</topic><topic>Medicine and Health Sciences</topic><topic>Metabolic disorders</topic><topic>Metabolic syndrome</topic><topic>Middle Aged</topic><topic>Non-alcoholic Fatty Liver Disease - diagnostic imaging</topic><topic>Patients</topic><topic>Population</topic><topic>Population studies</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Risk groups</topic><topic>Signs and symptoms</topic><topic>Statistical analysis</topic><topic>Steatosis</topic><topic>Transplants & implants</topic><topic>Ultrasonic imaging</topic><topic>Vibration</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eskridge, Wayne</creatorcontrib><creatorcontrib>Vierling, John M</creatorcontrib><creatorcontrib>Gosbee, Wayne</creatorcontrib><creatorcontrib>Wan, Gabriella A</creatorcontrib><creatorcontrib>Hyunh, May-Linh</creatorcontrib><creatorcontrib>Chang, Henry E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eskridge, Wayne</au><au>Vierling, John M</au><au>Gosbee, Wayne</au><au>Wan, Gabriella A</au><au>Hyunh, May-Linh</au><au>Chang, Henry E</au><au>Tokuhara, Daisuke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-11-30</date><risdate>2021</risdate><volume>16</volume><issue>11</issue><spage>e0260320</spage><epage>e0260320</epage><pages>e0260320-e0260320</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this non-communicable disease. Current screening guidelines do not recommend the routine screening of nonalcoholic fatty liver disease (NAFLD) for asymptomatic populations, so providers are not encouraged to actively seek disease, even in high-risk patients. This study sought to determine whether a self-selecting cohort of asymptomatic individuals would have scores based on vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP) significantly correlated to risk factors to suggest that routine screening for high-risk patients should be recommended. The study recruited 1,070 self-selected participants in Houston and Galveston County, Texas, 940 of which were included in final analysis. A pre-screening survey was used to determine eligibility. VCTE-based scores analyzed steatosis and fibrosis levels. Fifty-seven percent of the study population demonstrated steatosis without fibrosis, suggesting NAFLD, while 16% demonstrated both steatosis and fibrosis, suggesting NASH. Statistically significant risk factors included factors related to metabolic syndrome, race, and age, while statistically significant protective factors included consumption of certain foods and exercise. The findings of this study suggest that high-risk individuals should be screened for NAFLD even in the absence of symptoms and that community-based screenings are an effective tool, particularly in the absence of proactive guidelines for providers.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34847156</pmid><doi>10.1371/journal.pone.0260320</doi><orcidid>https://orcid.org/0000-0002-9717-5194</orcidid><orcidid>https://orcid.org/0000-0001-5547-6020</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2021-11, Vol.16 (11), p.e0260320-e0260320 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2604821983 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Adolescent Adult Aged Aged, 80 and over Alcohol Asymptomatic Attenuation Biology and Life Sciences Biopsy Comorbidity Diabetes Elasticity Imaging Techniques Fatty liver Female Fibrosis Food consumption Guidelines Health risks Humans Hypertension Lifestyles Liver Liver diseases Male Medicine and Health Sciences Metabolic disorders Metabolic syndrome Middle Aged Non-alcoholic Fatty Liver Disease - diagnostic imaging Patients Population Population studies Risk analysis Risk Factors Risk groups Signs and symptoms Statistical analysis Steatosis Transplants & implants Ultrasonic imaging Vibration Weight control |
title | Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T13%3A49%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20for%20undiagnosed%20non-alcoholic%20fatty%20liver%20disease%20(NAFLD)%20and%20non-alcoholic%20steatohepatitis%20(NASH):%20A%20population-based%20risk%20factor%20assessment%20using%20vibration%20controlled%20transient%20elastography%20(VCTE)&rft.jtitle=PloS%20one&rft.au=Eskridge,%20Wayne&rft.date=2021-11-30&rft.volume=16&rft.issue=11&rft.spage=e0260320&rft.epage=e0260320&rft.pages=e0260320-e0260320&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0260320&rft_dat=%3Cproquest_plos_%3E2604821983%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604821983&rft_id=info:pmid/34847156&rft_doaj_id=oai_doaj_org_article_6db50ebd9eee47edb077a78a6d7f5ec2&rfr_iscdi=true |